Alzheimer's vaccine: Nasal spray trial shows promise, researchers say
Researchers at Brigham and Women’s Hospital in Boston are testing an Alzheimer's vaccine on people.
The nasally administered vaccine, called Protollin, is being tested on a group of 16 people with early Alzheimer's disease, between the ages of 60 to 85 years.
Alzheimer's is a cognitive disease that impairs a memory, thought, and language. It is the most common type of dementia. In 2020, 569,600 Canadians were living with dementia.
"This (vaccine) is using some proteins to stimulate the body's own immune cells to clear away the beta-amyloid, which is really the problematic protein in Alzheimer's disease," Dr. Tanuja Chitnis, a neurologist with Brigham and Women’s Hospital, told CTV's Your Morning on Friday.
Amyloid is a protein that builds up in organs and can affect the heart, kidneys, liver, and nervous system.
The vaccine is showing positive results, but more testing is needed to understand dosages and any implications.
"We found that this drug is safe and well-tolerated," Chitnis said. "We're currently working on immunological studies to prove that the vaccine works in the way that we think it does."
If successful, this vaccine could drastically change the lives of people living with Alzheimer's, Chitnis said, allowing anyone to easily administer the drug. The Alzheimer Society of Canada says about 1 in 5 people have experienced caring for someone living with dementia.
"Our results suggested quite safe and patients with early Alzheimer's disease, and we're hoping that it will prevent patients from progressing into those later and more problematic stages of disease in which they can't take care of themselves," Chitnis said.
Another Alzheimer's vaccine has concluded trial results from the U.K., where a randomized placebo-controlled study showed there was a 27 per cent less decline in memory after 18 months.
Chitnis believes more research on Alzheimer's vaccines is "very exciting."
"We're seeing a lot of new treatments for Alzheimer's disease," she said. "Our approach is somewhat different, again, using the body's own immune cells to actually activate and clear away amyloid."
When asked about the trial, Joshua Armstrong, a research scientist with the Alzheimer Society of Canada, said the group would be watching for results.
"This vaccine-like approach of using a nasal spray to activate the body's immune system is a novel and innovative way of potentially addressing the beta amyloid plaques that build up in the brains of people living with Alzheimer's disease," Armstrong said in an email to CTVNews.ca Friday.
"If this treatment passes this Phase 1 trial, which examines the safety and tolerability in just 16 individuals with early-stage Alzheimer's disease, we will be following the future trials of Protollin to see if they result in the reduction of amyloid plaques and the slowing or reversal of cognitive decline in a larger group of patients."
COVID-19 COVERAGE
CTVNews.ca Top Stories
BREAKING | Canada deploys military assessment team to Turkiye after earthquake
A senior government official says a Canadian military assessment team is on its way to Turkiye in the wake of a devastating earthquake that's killed thousands.

'It was a nightmare': 2 children dead, driver charged after city bus crashes into Laval daycare
A man has been arrested and two children are dead after a driver crashed a city bus into a daycare in Laval, Que. Wednesday morning. The deadly crash sent multiple children to area hospitals and parents scrambling to find their kids shortly after they dropped them off for the day at the Garderie éducative Sainte-Rose, north of Montreal.
New one-and-done therapy can help curb severe COVID-19 infection: Canadian-led study
A Canadian-led study of a new potential antiviral therapy shows a single dose can help cut the risk of hospitalization and death from COVID-19.
opinion | Before you do your taxes, take note of these tax credits and deductions you may not have known about
Many Canadians are experiencing strains caused by the increased cost of living and inflation. In his exclusive column for CTVNews.ca, contributor Christopher Liew shares some of the top credits and deductions that you may be able to claim on your income tax return to help you save money.
Uber brings back pooled rides to Toronto, Montreal, Vancouver
Ride-hailing app Uber has brought back its carpooling service in Toronto, Montreal and Vancouver after a nearly three-year hiatus due to COVID-19 concerns.
Tyre Nichols documents: Officer never explained stop to him
The officer who pulled Tyre Nichols from his car before police fatally beat him never explained why he was being stopped, newly released documents show, and emerging reports from Memphis residents suggest that was common.
5 key takeaways from the BoC's first summary of interest rate deliberations
In a first for the Bank of Canada, it has released a summary of deliberations by its governing council regarding its policy decision to raise its key interest rate target by a quarter of a percentage point to 4.5 per cent in January. Here are five key takeaways from those discussions.
Netflix Canada begins password sharing crackdown
Netflix Canada is rolling out its long-anticipated plans to crack down on password sharing, saying it will begin notifying Canadian users today by email about limitations.
Health-care workers have new hand-washing guidelines. Here's how you can apply them
The way respiratory viruses have circulated this fall and winter, most Canadians could probably benefit from a hand-hygiene refresher. Here are the latest hand-washing best practices to apply in your daily life.